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Abstract An early sign of human myoblast commitment to
fusion is the expression of a non-inactivating delayed rectifier K+
current, IK(NI), and an associated membrane potential hyperpo-
larization. We have isolated the full-length coding region of a
human ether-a-go-go K+ channel (h-eag) from myoblasts under-
going differentiation. The h-eag gene was localized to chromo-
some 1q32^41, and is expressed as a V9 kb transcript in
myogenic cells and in adult brain tissue. Forced expression of
h-eag in undifferentiated myoblasts generates a current with
remarkable similarity to IK(NI) indicating that h-eag constitutes
the channel responsible for this current in vivo.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Myoblast fusion is a complex pattern of coordinated and
temporally separable events which include withdrawal from
the cell cycle, cell-cell interactions, adhesion, alignment, and
¢nal membrane fusion to form the multinucleated skeletal
muscle ¢ber.
Studies on myogenic cells from various species have shown
that their membrane resting potential undergoes a hyperpolar-
ization from approximately 310 mV in undi¡erentiated pro-
liferating myoblasts to values ranging between 355 mV and
370 mV in multinucleated myotubes [1^4]. When human my-
oblasts are induced to di¡erentiate, we observe that their rest-
ing potential hyperpolarizes through the sequential expression
of two voltage-gated potassium currents [5]. The ¢rst is a non-
inactivating delayed recti¢er current (IKNI) that hyperpolar-
izes the cell to an intermediate resting potential of approxi-
mately 332 mV [6]. Then, slightly before fusion, an inward
recti¢er current is expressed (IKIR) and drives the potential
further down to approximately 365 mV, i.e. similar to that
measured for multinucleated myotubes. A pharmacological
blockade of IKIR depolarizes myoblasts to a resting potential
of about 330 mV and prevents their fusion [5]. The role of
IKNI in myoblast fusion is more di⁄cult to assess, as there
are, as yet, no pharmacological agents available to speci¢cally
block this current.
The present work was undertaken to elucidate the molec-
ular nature of the KNI channel that is activated at the onset
of human myoblast di¡erentiation. As KNI channels produce
a current whose electrophysiological characteristics closely re-
semble those of the current evoked by the rat ether-a-go-go (r-
eag) potassium channel [7^10], we searched for an eag homo-
log in human myogenic cells. We report here the cloning of a
human cDNA encoding a member of the ether-a-go-go potas-
sium channel family and show that it constitutes the KNI
channel expressed in vivo.
2. Materials and methods
2.1. Cell cultures
Biopsies of human skeletal muscle were obtained during corrective
orthopedic surgery of young patients (9 months to 17 years old) with-
out any known neuromuscular disease, in accordance with the guide-
lines of the ethical committee of the University Hospital of Geneva,
Switzerland (written informed consent was obtained from the patients
or their legal guardians). Myoblast clonal cultures were prepared from
satellite cells, proliferated in a growth medium and induced to fuse by
transfer to a di¡erentiation medium (DM) as described previously
[11]. Fusion-competent myoblasts were obtained by plating myoblasts
at a very low density in DM. Under these conditions, the cells are
induced to di¡erentiate but prevented from fusing [12].
2.2. h-eag cDNA cloning and sequencing
Template cDNA was prepared from human di¡erentiating myo-
blast RNA, isolated as described [13]. RT-PCR was performed using
oligonucleotide primers EAGF1 (5P-AACGACACTAATTTTGTG-
TTGGG-3P) and EAGR1 (5P-CTTCTTGTACATCAGAATTTCG-
3P) corresponding to nucleotides 285^307 and 494^515 of rat eag,
respectively. Touchdown PCR conditions (60‡C to 50‡C over 30
cycles) produced a 230 bp fragment which was cycle-sequenced, and
used to generate a radiolabeled probe to screen a custom-made ZAP
express cDNA library (Stratagene) prepared from RNA isolated from
human di¡erentiating myoblasts (myoblasts cultured in DM for 24^48
h; clonal cultures were from several biopsies). Plaque lifts were per-
formed on nylon membranes, and hybridization carried out at 65‡C
according to the manufacturer’s protocol (DuPont NEN). Further
library screening was performed using a PCR probe derived from
the 3P-most region of the clone isolated in the initial screening
(generated with primers EAGF6: 5P-GGAGATGTGTTCTGGA-
AGGAA-3P ; and EAGR8: 5P-ACGTCGCTGATCTTCCGGAAC-
ACA-3P). Sequences were determined on both strands.
2.3. Northern blot analysis
Human myogenic cell RNA was probed with a radiolabeled 765 bp
PCR product generated from S5 transmembrane segment and C-ter-
minal sequences of h-eag. Hybridization was performed as described
[14]. Hybridizations of a multiple tissue Northern blot (Clontech)
were performed as per manufacturer’s protocol. A 182 bp PCR-radio-
labeled probe was generated from the 5P untranslated and 5P coding
sequence of h-eag. To probe for h-eag2, a 264 bp PCR-radiolabeled
probe to the 3P end of the gene and encompassing the stop codon
(with 224 bp of 3P untranslated region) was used.
2.4. Chromosome mapping of h-eag
The chromosomal location of h-eag was determined by PCR using
two di¡erent somatic cell hybrid panels: the monochromosomal hy-
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brid cell panel of human-rodent hybrid cell lines (NIGMS [15]) and
the Genebridge 4 Radiation Hybrid DNA panel from the HGMP
Resource Centre, UK [16]. The PCR oligonucleotides used were
EAGF6, derived from the h-eag coding sequence, and EAGR13 (5P-
ATGATCCAGCTAGGGCATGAGG-3P) derived from a down-
stream intron. Cell lines giving the expected 300 bp PCR product
were identi¢ed by Southern analysis using a labeled exonic 205 bp
PCR product generated using primers EAGF6 and EAGR8. Results
were analyzed at http://www-genome.wi.mit.edu/cgi-bin/contig/
rhmapper.pl. The position of h-eag relative to the Genethon chromo-
some 1 linkage map (July, 1997) was deduced using Mapview 2.0 from
the Genome database (http://www.gdb.org).
2.5. Bicistronic h-eag-GFP expression vector construction
A full-length cDNA clone was reconstructed in pBluescript II (Stra-
tagene) to contain the full open reading frame (2886 bp), 116 bp of 5P
untranslated sequence and 43 bp of 3P untranslated sequence. The
h-eag-GFP bicistronic vector was generated by inserting a 3 kb frag-
ment of h-eag into the expression vector pcDNA3/IRES-GFP. The
latter vector was constructed by inserting an IRES-GFP cassette in
pcDNA3 (Invitrogen). The IRES element of EMCV was excised from
a vector kindly provided by E. Wimmer (State University of New
York, Stony Brook, NY), and the GFP DNA was excised from
phGFP-S65T (Clontech).
2.6. h-eag expression in human myoblasts
Human proliferating myoblasts (seeded in 35 mm Costar dishes)
were transfected at 50^70% cell con£uence with a 1:2 ratio of DNA
(3^5 Wg plasmid) to DAC-30 transfection agent (Eurogentec), in 1 ml
of medium (in the presence of FCS), for 9^14 h at 37‡C, after which
the medium was completely replaced by fresh growth medium. Re-
cordings were done 36^48 h after transfection. Control cells were
mock-transfected with a pcDNA3/IRES-GFP vector without a ¢rst
cistron.
2.7. Electrophysiology
Whole-cell con¢guration of the patch-clamp technique [17] was
used to measure ionic currents as described in [6]. Recordings were
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Fig. 1. Alignment of the deduced amino acid sequence of human eag (h-eag) with rodent homologs (r-eag and m-eag), the prototype Drosophila
eag (d-eag) and the partial sequence of a presumptive second human eag (h-eag2). Sequence alignments were created using ClustalW [38] and
shaded using the Genedoc program (at http://www.cris.com/Vketchup/gddl.htm). Black shading indicates identity in all sequences when align-
ment includes h-eag2. Shading is in gray when residues are identical in three or four of the sequences. Amino acid residues are numbered on
the right. Gaps in the alignment are indicated by dashes. The double slash (//) indicates interruption in the d-eag sequence (only the ¢rst 1001
residues were aligned). The six putative transmembrane segments (S1^S6), the pore-forming region (P) and the putative cyclic nucleotide bind-
ing domain (cNBD) are overlined. Putative post-translational modi¢cation sites for h-eag are indicated: (b) for N-glycosylation, (8) for protein
kinase C, and (*) for cAMP- and cGMP-dependent protein kinases. Only those sites that are presumably accessible are indicated. The arrow
indicates the position of an intron found unspliced in one h-eag cDNA clone. The h-eag cDNA sequence has been submitted to the EMBL
data bank (accession number AJ001366).
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performed in absence of extracellular Ca2 and in presence of intra-
cellular BAPTA (20 mM) to prevent activation of Ca2-activated
potassium channels present in human myoblasts [4]. The extracellular
solution was composed of (in mM): NMG-Cl 100, KCl 5, MgCl2 3,
HEPES 5, NaOH 50, acetic acid 50, and glucose 8. The pH was
adjusted to 7.4 with NMG. The intracellular (pipette) solution was
(in mM): KCl 110, NaCl 5, MgCl2 1, HEPES 5, BAPTA 20, and
glucose 5. The pH was adjusted to 7.4 with KOH. Statistics: all data
are expressed as the means þ S.E.M.
3. Results
3.1. Isolation of h-eag from human myoblasts undergoing
di¡erentiation
A DNA alignment was carried out between the eag super-
family potassium channel members rat eag [7], mouse eag and
human erg [18]. Oligonucleotides for PCR ampli¢cation were
designed to a conserved area in the 5P regions of the sequences
such that primer sequences were identical between rat and
mouse eag but di¡erent in human erg. A PCR product of
the expected size (230 bp) was obtained from human myogen-
ic cell cDNA. Its sequence had 87% and 89% nucleotide iden-
tity to rat and mouse eag and thus it was assumed to be the
human eag (h-eag). This PCR product was used as a probe to
screen a cDNA library made from human di¡erentiating myo-
blasts (900 000 phages). The single positive h-eag clone iso-
lated had an insert of 2033 bp which lacked the initiating
methionine and stop codon. Further screening of 1.2 million
phages, using the same probe as above, as well as a 205 bp
probe derived from the 3P-most end of the original clone,
resulted in the isolation of a further 12 positive clones, among
which two separate clones contained an initiating ATG co-
don, consistent with the rat and mouse eag sequences, and a
termination codon.
The combined sequence of these overlapping clones re-
vealed an open reading frame of 2886 bp, encoding a deduced
h-eag protein of 962 amino acids with a predicted molecular
mass of 108 kDa. The protein shows 97% and 94% overall
amino acid identity with the rat and mouse eag proteins re-
spectively, con¢rming its identity as human eag (Fig. 1). A
polymorphism at nucleotide 2225 [C or T], which does not
change the coding amino acid (Asp-685), was observed in
di¡erent cDNA clones. One cDNA clone, derived from an
incompletely spliced eag RNA, showed the presence of an
intron of at least 1.3 kb at nucleotide 2201 of the cDNA
sequence (arrow at Arg-667 in Fig. 1). A recent study on
gene structure of another member of the eag superfamily,
mouse erg [19], showed the presence of an intron at the equiv-
alent position (at Thr-865 of mouse erg).
Alignment of the h-eag protein sequence with other eag
members shows that it shares the structural features of the
eag superfamily of potassium channels (Fig. 1): a central hy-
drophobic core containing six putative transmembrane seg-
ments (S1^S6) £anked by long presumptive cytoplasmic N-
and C-termini, the putative pore region (P) between trans-
membrane segments S5 and S6, and a highly conserved puta-
tive cyclic nucleotide binding domain (cNBD) downstream
from S6 [20]. Further analysis using the PROSITE program
[21] shows six consensus sites for N-glycosylation, as well as
three consensus phosphorylation sites for cAMP- and cGMP-
dependent protein kinases, 18 sites for casein kinase II, and 16
consensus sites for protein kinase C.
3.2. h-eag mRNA is expressed in myogenic cells and adult brain
Northern blot analysis revealed a h-eag transcript of ap-
proximately 9 kb in cultured myogenic cells (Fig. 2A) and
in adult brain (eight adult tissues tested, Fig. 2B). After a
longer exposure, a faint band of the same size appeared in
placental mRNA but no transcript could be detected in adult
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Fig. 2. Northern blot analysis of h-eag expression in cultured myogenic cells and various adult tissues. A: Total RNA (20 Wg) extracted from
freshly formed myotubes were loaded and a 32P-PCR-labeled 765 bp product was used as probe. B: Multiple human adult tissue Northern blot
(Clontech, 2 Wg of poly(A) RNA per lane) probed with a 32P-labeled 182 bp probe. Tissue origin as stated at the top of each lane. Migration
of an RNA ladder is indicated on the left of each blot.
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skeletal muscle mRNA suggesting that h-eag transcripts are
expressed at low levels in the adult tissue, or that h-eag chan-
nels are transiently expressed during muscle development (see
Section 4).
3.3. h-eag maps to chromosome 1q32^41
The chromosomal localization of the h-eag gene was carried
out by PCR analysis of two di¡erent human-rodent somatic
cell hybrid panels (see Materials and Methods). A human
speci¢c PCR product was obtained using a primer in h-eag
coding sequence and a primer in intronic sequence, found in
the incompletely spliced cDNA clone (data not shown). The
gene was found to map to human chromosome 1 and was
further ¢ne mapped between the genetic markers D1S217
and D1S204, corresponding to region 1q32^41.
3.4. A presumptive second eag gene product was not detected in
human di¡erentiating myoblasts
While screening for human eag in our system, BLAST ho-
mology searches revealed the existence of a human EST
(F05455) in the expressed sequence tag database generated
from sequencing studies in the human genome project. This
EST, isolated from an adult brain cDNA library, presented
signi¢cant homology to the C-terminal region of r-eag, and its
corresponding I.M.A.G.E. Consortium (LLNL) Clone (ID
21313 [22]) was mapped to human chromosome 14 (between
D14S997 and D14S63 [23]). We obtained and fully sequenced
this clone which contains an insert of 1704 bp, including a
stop codon at base 1400, a polyadenylation signal and a poly
A tail. This clone was recently sequenced independently by
other researchers and submitted to GenBank (accession num-
ber U69185).
An alignment of overlapping areas (see Fig. 1) shows that
h-eag and the eag-like I.M.A.G.E. clone share 58% amino
acid identity over a total overlap of 467 amino acids. To
determine whether this putative second eag member might
also be expressed in myogenic cells, we performed RT-PCR
using several PCR conditions, but failed to amplify this prod-
uct in myogenic cells. In addition, the 3P-most h-eag probe
used to screen our cDNA library was highly homologous to
the I.M.A.G.E. clone sequence, and, in the conditions used, is
likely to have hybridized to any eag-like clones derived from
this second transcript. Instead, it only detected h-eag clones,
suggesting that the presumptive h-eag2 is not expressed in
myoblasts undergoing di¡erentiation. Furthermore, analyses
by Northern blotting could not show presence of h-eag2 tran-
scripts in myogenic cells, but detected a transcript of s 11 kb
in adult brain tissue only (using a multiple adult human tissue
blot; data not shown).
3.5. Expression of h-eag current recorded in h-eag-transfected
undi¡erentiated human myoblasts
To test whether h-eag mRNA could encode functional KNI
channels, we overexpressed h-eag in undi¡erentiated myo-
blasts. At that stage, the cells are proliferating and do not
express active KNI channels, or only at a very low density
[6], nor do they express any delayed recti¢er current (IKDR
[4]). For these expression studies, a bicistronic h-eag-GFP
vector was constructed by inserting the h-eag sequence up-
stream of an internal ribosomal entry site [24] followed by
the sequence encoding green £uorescent protein [25].
Fig. 3A illustrates whole-cell characteristics of the outward
current (Ihÿeag) recorded in transfected undi¡erentiated myo-
blasts. A whole-cell outward current of the amplitude shown
in Fig. 3A (inset) was never observed in untransfected myo-
blasts, nor in mock-transfected cells. For comparison, the
mean conductance at +40 mV in h-eag-transfected myoblasts
is approximately 100 times larger than that occasionally ob-
served in some undi¡erentiated myoblasts expressing a very
low density of IKNI.
Like IKNI, Ihÿeag activates above 350 mV and does not
inactivate during sustained depolarization. The steady-state
conductances were computed by dividing the current recorded
during various voltage steps (see inset) by the driving force on
potassium ions (EK =378 mV), and the conductance-voltage
relationship was ¢tted with a Boltzmann equation (Fig. 3). In
10 h-eag-transfected myoblasts, the gating charge of Ihÿeag
was 1.55 þ 0.03 times the elementary charge, Vo was
34.1 þ 2.1 mV, and Gr;max was 1401 þ 365 pS/pF. Except
for Gr;max, which is about 10 times larger than for IKNI in
fusion-competent cells, re£ecting a high level of h-eag expres-
FEBS 20735 27-8-98
Fig. 3. Properties of h-eag current. Recordings were performed in
green £uorescent undi¡erentiated myoblasts (A) or COS-7 cells (B),
48 h after transfection with a bicistronic h-eag-GFP vector. Whole-
cell outward currents were measured at the end of 600 ms steps and
leak current subtracted. The leak current was determined in pres-
ence of 90 mM TEA and 5 mM Ba2. Steady-state conductances
were plotted against step potentials and were well described by a
Boltzmann equation. Insets: Voltage-dependent activation of h-eag
channels at di¡erent voltage steps. Cell capacitance was 24 pF for
A, and 35 pF for B.
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sion in the transfected cells, these results are similar to those
obtained for IKNI recorded in fusion-competent myoblasts
[6]. COS-7 cells, which do not express any endogenous IKNI
or IKDR, were transfected in parallel and, as shown in Fig.
3B, the currents elicited by h-eag in these cells (n = 5) were
identical to those obtained with transfected myoblasts.
4. Discussion
The possibility to examine the evolution of membrane elec-
trical properties during human myoblast fusion using primary
cultures at de¢ned stages of di¡erentiation has allowed us to
show that an initial hyperpolarization of the resting potential
is associated with the expression of a non-inactivating delayed
recti¢er potassium current, IKNI [6]. Undi¡erentiated myo-
blasts that are actively proliferating do not express IKNI or
only at a very low density. When the cells are induced to
di¡erentiate, the current density increases rapidly and mark-
edly, and then steeply declines upon formation of myotubes,
indicating that IKNI expression peaks before the cells fuse [5].
Similarities between IKNI and that elicited by r-eag channels
[7^10] prompted us to search for an eag homolog in myoblasts
undergoing di¡erentiation.
The human eag sequence isolated produces a functional
non-inactivating delayed recti¢er potassium channel, whose
properties at the whole-cell and single-channel levels are in-
distinguishable from those of the endogenous IKNI expressed
in fusion-competent myoblasts [10], indicating that h-eag is
the molecular entity constituting the KNI channel expressed
at onset of human myoblast fusion. The presence of h-eag
transcripts in cultured myogenic cells and the lack of detect-
able transcripts in adult skeletal muscle mRNA (see Fig. 2)
correlate with the changes of IKNI density [5], reinforcing our
belief that h-eag forms the KNI channel and that it may be
transiently expressed during myoblast di¡erentiation. Alterna-
tively, h-eag transcripts may be too scarce in adult tissues to
be detectable by Northern blotting, and, although IKNI den-
sity is downregulated upon myotube formation, it does not
completely disappear in freshly formed myotubes.
A presumptive second eag gene product could not be de-
tected in myogenic cells. Cloning of the full-length h-eag2
cDNA is required to ascertain if it indeed encodes a protein
having the structural features of eag potassium channels. The
detection of transcripts of two eag genes in adult brain tissue
raises the hypothesis that, if found colocalized in the nervous
system, the products of two eag genes could coassemble to
form heteromultimeric channels. Coassembly of two isoforms
of another member of the eag superfamily has been suggested
to occur in the mouse cardiac muscle [19].
Comprehensive mapping of the h-eag gene was performed
to determine whether its chromosomal location maps close to
any identi¢ed genetic syndrome. Several human genetic dis-
eases, such as certain forms of long-QT syndrome [26,27] and
of inherited epilepsy [28^30], have recently been demonstrated
to be due to mutations in potassium channel genes. The h-eag
gene was found to map to chromosome 1q32^41, an area to
which one form of a rare condition called rippling muscle
disease (RMD [31]) has been linked in one family. However,
it appears unlikely that mutations in the eag gene would be a
direct cause of this pathology as the symptoms presented
(muscle contraction waves unaccompanied by electrical sig-
nals) are not those that would be expected for an ion chan-
nel-linked de¢ciency at the level of the plasma membrane. A
search for mutations in the h-eag gene in RMD patients will
con¢rm whether there is any involvement in this disorder.
Myoblast fusion is intimately coupled with irreversible cell-
cycle arrest. The timing of cell-cycle withdrawal and the extent
of myoblast fusion clearly depend on environmental signals
and information provided by surrounding cells [32^34]. When
proliferating human myoblasts are transferred to di¡erentia-
tion-promoting medium, we observe that their membrane rest-
ing potential becomes rapidly hyperpolarized due to the ex-
pression of IKNI, and the activation of this current appears to
coincide with cell-cycle arrest. How the cell cycle can exert an
in£uence on plasma membrane electrical properties and con-
versely, how channel activity and membrane resting potential
exert an in£uence on the cell cycle are questions that are
receiving increasing attention [35^37]. The identi¢cation of
h-eag as the molecular entity of the potassium current that
contributes to the initial hyperpolarization of myoblasts will
allow examination of how h-eag expression and channel ac-
tivity are regulated during myoblast di¡erentiation and coor-
dinated with permanent cell-cycle withdrawal. These future
studies shall provide insight on the precise role of membrane
potential hyperpolarization in the sequence of events that
leads to myoblast fusion.
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